By Kristin Beerman | email
Edited by Jon Bush | email
LUBBOCK, TX (KCBD) - The government is one step closer to allowing boys to receive an HPV vaccine and a second similar vaccine could soon be on the market for girls.
An advisory panel of the Food and Drug Administration voted Wednesday to recommend Cervarix, instead of the controversial Gardisil vaccine recommended for young girls a few years ago, as another option to protect young girls against cervical cancer. The FDA panel said the data shows Cevarix is safe and effective in preventing two strains of the Human Papilloma Virus, which accounts for 70% of the cases of cervical cancer. If approved, Cevarix would be given to girls and women from age 10-25. Meanwhile, many health experts say they'd like to see boys get the same vaccine, because even though it's not cheap, Cevarix protects against genital warts and some rare cancers in men.
Kristin Rager, M.D., with Carolinas Medical Center said, "It's hard to say to a man who now has genital warts, you know this was $300. I'm sorry, this was just too much. How do you put a price on that?"
The FDA is not required to follow the committee's recommendations, but it usually does.
©2009 KCBD NewsChannel 11. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.